Astria Therapeutics

Catabasis Pharmaceuticals is a biopharmaceutical company located in Cambridge, Massachusetts focused on the discovery and development of innovative drugs to treat inflammatory conditions. Their platform technology enables the discovery and development of small molecules that simultaneously and specifically target pathways in the inflammatory response. The Catabasis platform will lead to the development of a novel mechanism of action therapies to safely and effectively treat inflammatory diseases.

Astria Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical, Biopharma sector. The company focuses on Biotechnology and has secured $178.6B in funding across 272 round(s). With a team of 11-50 employees, Astria Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Debt Financing - Astria Therapeutics, raised $2.0M. Discover more about their projects, partnerships, and impact on our platform.